Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Selective breeding can enhance immunity in dairy cattle.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

ALKBH5 helps wounds heal faster by stabilizing PELI2 mRNA.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Atopic dermatitis shows a link between skin layers in inflammation, detectable with detailed gene analysis.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

SM04755 may be an effective topical treatment for psoriasis.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.